ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products.
Financial Results:
ERIS Lifesciences Ltd reported Revenues for Q4FY25 of ₹705.00 Crores up from ₹551.00 Crore year on year, a rise of 27.95%.
Total Expenses for Q4FY25 of ₹584.00 Crores up from ₹489.00 Crores year on year, a rise of 19.43%.
Consolidated Net Profit of ₹102.00 Crores up 27.5% from ₹80.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹6.89, up 31.99% from ₹5.22 in the same quarter of the previous year.